Insider Profile
LeBlanc, Christopher Thomas Francis
1
Companies Filed At
3
Open-Market Buys (2yr)
$40K
Buy Value (2yr, open-market)
Jun 08, 2026
Most Recent Trade
Currently Accumulating Companies this insider is net-buying on the open market over the last 90 days
Date Company Role Nature Dir. Shares Price Value Score
Jun 08, 2026 $NLH
Nova Leap Health Corp.
Open Market Buy 50,000 $0.38 $19K 55
Jun 05, 2026 $NLH
Nova Leap Health Corp.
Open Market Buy 2,471 $0.36 $890 55
Dec 11, 2025 $NLH
Nova Leap Health Corp.
Comp. Grant Buy 200,000 $0.35 $70K 55
Jun 13, 2025 $NLH
Nova Leap Health Corp.
Open Market Buy 72,000 $0.28 $20K 55
Dec 13, 2023 $NLH
Nova Leap Health Corp.
Open Market Buy 30,500 $0.25 $8K 55
Dec 12, 2023 $NLH
Nova Leap Health Corp.
Open Market Buy 49,500 $0.25 $12K 55
Dec 06, 2023 $NLH
Nova Leap Health Corp.
Comp. Grant Buy 150,000 $0.35 $52K 55
Aug 30, 2023 $NLH
Nova Leap Health Corp.
Open Market Buy 20,000 $0.17 $4K 55
Aug 28, 2023 $NLH
Nova Leap Health Corp.
Open Market Buy 20,000 $0.17 $3K 55
Aug 28, 2023 $NLH
Nova Leap Health Corp.
Open Market Buy 20,000 $0.18 $4K 55
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.